Lee JC - Search Results

1

Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung.

Jang YJ, Hyun DG, Choi CM, Lee DH, Kim SW, Yoon S, Kim WS, Ji W, Lee JC. Jang YJ, et al. Among authors: lee dh, lee jc. BMC Cancer. 2021 Jun 26;21(1):731. doi: 10.1186/s12885-021-08472-6. BMC Cancer. 2021. PMID: 34174841 Free PMC article.

2

Gastrointestinal metastasis of lung cancer with special emphasis on a long-term survivor after operation.

Kim MS, Kook EH, Ahn SH, Jeon SY, Yoon JH, Han MS, Kim CH, Lee JC. Kim MS, et al. Among authors: lee jc. J Cancer Res Clin Oncol. 2009 Feb;135(2):297-301. doi: 10.1007/s00432-008-0424-0. Epub 2008 May 30. J Cancer Res Clin Oncol. 2009. PMID: 18512073

3

Age at diagnosis predicts outcomes in gefitinib-treated female patients with non-small-cell lung cancer.

Na II, Choe du H, Kim CH, Koh JS, Ryoo BY, Lee JC, Yang SH. Na II, et al. Among authors: lee jc. Lung Cancer. 2010 May;68(2):295-8. doi: 10.1016/j.lungcan.2009.06.005. Epub 2009 Jul 2. Lung Cancer. 2010. PMID: 19576656

4

Kim HR, Kang MS, Na II, Yang SH, Choi YH, Kang HJ, Kim CH, Lee JC. Kim HR, et al. Among authors: lee jc. J Cancer Res Clin Oncol. 2010 Apr;136(4):547-52. doi: 10.1007/s00432-009-0687-0. Epub 2009 Sep 30. J Cancer Res Clin Oncol. 2010. PMID: 19789893

5

Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy-naive patients with extensive-disease small cell lung cancer.

Lee DH, Kim SW, Suh C, Lee JS, Ahn JS, Ahn MJ, Park K, Na II, Lee JC, Ryoo BY, Yang SH. Lee DH, et al. Among authors: lee js, lee jc. Cancer. 2010 Jan 1;116(1):132-6. doi: 10.1002/cncr.24719. Cancer. 2010. PMID: 19904804 Free article. Clinical Trial.

6

Combined treatment with silibinin and epidermal growth factor receptor tyrosine kinase inhibitors overcomes drug resistance caused by T790M mutation.

Rho JK, Choi YJ, Jeon BS, Choi SJ, Cheon GJ, Woo SK, Kim HR, Kim CH, Choi CM, Lee JC. Rho JK, et al. Among authors: lee jc. Mol Cancer Ther. 2010 Dec;9(12):3233-43. doi: 10.1158/1535-7163.MCT-10-0625. Mol Cancer Ther. 2010. PMID: 21159609

7

The effect of acquired cisplatin resistance on sensitivity to EGFR tyrosine kinase inhibitors in EGFR mutant lung cancer cells.

Rho JK, Choi YJ, Choi YR, Kim SY, Choi SJ, Choi CM, Na II, Lee JC. Rho JK, et al. Among authors: lee jc. Oncol Res. 2011;19(10-11):471-8. doi: 10.3727/096504012x13285365944337. Oncol Res. 2011. PMID: 22715590

8

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.

Zhang Z, Lee JC, Lin L, Olivas V, Au V, LaFramboise T, Abdel-Rahman M, Wang X, Levine AD, Rho JK, Choi YJ, Choi CM, Kim SW, Jang SJ, Park YS, Kim WS, Lee DH, Lee JS, Miller VA, Arcila M, Ladanyi M, Moonsamy P, Sawyers C, Boggon TJ, Ma PC, Costa C, Taron M, Rosell R, Halmos B, Bivona TG. Zhang Z, et al. Among authors: lee dh, lee jc, lee js. Nat Genet. 2012 Jul 1;44(8):852-60. doi: 10.1038/ng.2330. Nat Genet. 2012. PMID: 22751098 Free PMC article.

9

CT findings in non-small-cell lung cancer patients treated with gefitinib or erlotinib.

Na II, Choe du H, Kim CH, Park SH, Park JH, Lee JC. Na II, et al. Among authors: lee jc. J Cancer Res Ther. 2012 Apr-Jun;8(2):247-53. doi: 10.4103/0973-1482.98979. J Cancer Res Ther. 2012. PMID: 22842370 Free article.

10

False-positive FDG-PET and bronchial anthracofibrosis.

Kim MA, Lee JC, Choi C. Kim MA, et al. Among authors: lee jc. J Thorac Oncol. 2012 Sep;7(9):1474. doi: 10.1097/JTO.0b013e318260ded4. J Thorac Oncol. 2012. PMID: 22895146 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,843 results

Search Page